PREDICTING

PROFILE is a randomised, multi-centre, biomarker-stratified, open-label trial in patients newly diagnosed with Crohn's disease... PROFILE aims to demonstrate that a prognostic biomarker can enable delivery of personalised therapy in Crohn's disease, and that this improves clinical outcomes... Homepage for the PROFILE Study, the biomarker stratified clinical trial for Crohn's disease. The page provides information of the design and aims of the clinical trial, and also covers inclusion and exclusion criteria.

Primary location: Cambridge United Kingdom